<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">EFSA J</journal-id><journal-id journal-id-type="iso-abbrev">EFSA J</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)1831-4732</journal-id><journal-id journal-id-type="publisher-id">EFS2</journal-id><journal-title-group><journal-title>EFSA Journal</journal-title></journal-title-group><issn pub-type="epub">1831-4732</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7691614</article-id><article-id pub-id-type="doi">10.2903/j.efsa.2020.e181112</article-id><article-id pub-id-type="publisher-id">EFS2E181112</article-id><article-categories><subj-group subj-group-type="overline"><subject>EU&#x02010;FORA Series 3</subject></subj-group><subj-group subj-group-type="heading"><subject>EU&#x02010;FORA Series 3</subject></subj-group></article-categories><title-group><article-title>Risk assessment regarding the use of <italic>Annona muricata</italic> in food supplements</article-title></title-group><contrib-group><contrib id="efs2e181112-cr-0001" contrib-type="author" corresp="yes"><collab collab-type="authors">German Federal Institute for Risk Assessment (BfR), Department of Food Safety, Berlin, Germany</collab><address><email>eu-fora@efsa.europa.eu</email></address></contrib><contrib id="efs2e181112-cr-0002" contrib-type="author"><name><surname>Raclariu&#x02010;Manolica</surname><given-names>Ancuta Cristina</given-names></name></contrib><contrib id="efs2e181112-cr-0003" contrib-type="author"><name><surname>Bakhiya</surname><given-names>Nadiya</given-names></name></contrib><contrib id="efs2e181112-cr-0004" contrib-type="author"><name><surname>Hirsch&#x02010;Ernst</surname><given-names>Karen Ildico</given-names></name></contrib></contrib-group><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence:</bold><email>eu-fora@efsa.europa.eu</email></corresp></author-notes><pub-date pub-type="epub"><day>26</day><month>11</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>11</month><year>2020</year></pub-date><volume>18</volume><issue>Suppl 1</issue><issue-id pub-id-type="doi">10.1002/efs2.v18.S1</issue-id><issue-title content-type="special-issue-title">EU&#x02010;FORA Series 3</issue-title><elocation-id>e181112</elocation-id><permissions><!--<copyright-statement content-type="issue-copyright">&#x000a9; European Food Safety Authority<copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2020 European Food Safety Authority. <italic>EFSA Journal</italic> published by John Wiley and Sons Ltd on behalf of European Food Safety Authority.</copyright-statement><license license-type="creativeCommonsBy-nd"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nd/4.0/">http://creativecommons.org/licenses/by-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited and no modifications or adaptations are made.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:EFS2-18-e181112.pdf"/><abstract id="efs2e181112-abs-0001"><title>Abstract</title><p>The current risk assessment was performed in the context of the European Food Risk Assessment Fellowship Programme (<styled-content style="fixed-case" toggle="no">EU</styled-content>&#x02010;<styled-content style="fixed-case" toggle="no">FORA</styled-content>) supported by <styled-content style="fixed-case" toggle="no">EFSA</styled-content> and was intended to evaluate possible health risks associated with the consumption of <italic>Annona muricata</italic> L. (Annonaceae) and derived food supplements. <italic>A.&#x000a0;muricata</italic> grows as a tree and is native to the Caribbean and Central America. Preparations made from different plant parts of <italic>A. muricata</italic> (i.e. fruit, leaves, bark, roots) have been used as herbal medicine and are also marketed worldwide as over&#x02010;the&#x02010;counter food supplements that have been purported to support general health or to treat a wide range of health conditions, particularly cancer and parasitic infections. However, open questions remain regarding the safety of <italic>A. muricata</italic>&#x02010;based food supplements, since Annonaceae have been reported to contain potentially neurotoxic compounds, i.e. acetogenins. The assessment conducted within the present fellowship programme shows that substantial uncertainties exist regarding the safe use of <italic>A. muricata</italic>&#x02010;based supplements. The available data provide indications of neurotoxic potential of certain <italic>A. muricata</italic> preparations. The paucity of adequate studies, particularly related to long&#x02010;term use of <italic>A. muricata</italic> supplements, currently does not allow the establishment of a safe intake level. Within this technical report a workflow of the project is presented.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="efs2e181112-kwd-0001"><italic>Annona muricata</italic> L.</kwd><kwd id="efs2e181112-kwd-0002">annonacin</kwd><kwd id="efs2e181112-kwd-0003">botanical preparation</kwd><kwd id="efs2e181112-kwd-0004">food</kwd><kwd id="efs2e181112-kwd-0005">food supplement</kwd><kwd id="efs2e181112-kwd-0006">neurotoxicity</kwd><kwd id="efs2e181112-kwd-0007">risk assessment</kwd></kwd-group><counts><fig-count count="0"/><table-count count="1"/><page-count count="10"/><word-count count="4523"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>November 2020</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.9.4 mode:remove_FC converted:27.11.2020</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="self-citation" id="efs2e181112-cit-1001">
<bold>Suggested citation:</bold>
<collab collab-type="authors">German Federal Institute for Risk Assessment (BfR), Department of Food Safety, Berlin, Germany</collab>
, <string-name>
<surname>Raclariu&#x02010;Manolica</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Bakhiya</surname>
<given-names>N</given-names>
</string-name> and <string-name>
<surname>Hirsch&#x02010;Ernst</surname>
<given-names>KI</given-names>
</string-name>, <year>2020</year>
<article-title>Risk assessment regarding the use of <italic>Annona muricata</italic> in food supplements</article-title>. <source xml:lang="en">EFSA Journal</source> 2020;18(S1):e181112, 10 pp. <pub-id pub-id-type="doi">10.2903/j.efsa.2020.e181112</pub-id>
</mixed-citation>
</p><fn-group id="efs2e181112-ntgp-0001"><fn id="efs2e181112-note-1001"><p>
<bold>Acknowledgements:</bold> This report is funded by EFSA as part of the EU&#x02010;FORA programme.</p></fn><fn id="efs2e181112-note-1002"><p>Approved: 7 September 2020</p></fn></fn-group></notes></front><body id="efs2e181112-body-0001"><sec id="efs2e181112-sec-0002"><label>1</label><title>Introduction</title><sec id="efs2e181112-sec-0003"><label>1.1</label><title>European Food Risk Assessment Fellowship Programme (EU&#x02010;FORA)</title><p>The EU&#x02010;FORA programme supported by the European Food Safety Authority (EFSA) offers an opportunity to professionals within the European Union (EU) to increase their knowledge and experience in food safety risk assessment (Bronzwaer et&#x000a0;al., <xref rid="efs2e181112-bib-0005" ref-type="ref">2016</xref>). The aim of the programme is to contribute to the expansion of the EU<bold>&#x02019;</bold>s community of scientists working in the field of risk assessment and thus to increase both the pool of experts and to support cooperation with respect to food safety risk assessment activities at both the national and EU levels (Bronzwaer et&#x000a0;al., <xref rid="efs2e181112-bib-0005" ref-type="ref">2016</xref>).</p><p>The EU&#x02010;FORA fellow was hosted by the German Federal Institute for Risk Assessment (BfR), Department of Food Safety, Unit of Nutritional Risks, Allergies and Novel Foods. Within the agreed work programme that was entitled &#x02018;Risk assessment of botanical preparations used in food supplements and fortified foods&#x02019;, the main task of the fellow was the preparation of a monograph regarding the risk assessment of <italic>Annona muricata</italic> and preparations derived thereof with respect to use in food supplements.</p></sec><sec id="efs2e181112-sec-0004"><label>1.2</label><title>General background regarding the risk assessment</title><p>The use of herbal preparations has gained popularity in industrialised countries as complementary or alternative approach to pharmacotherapy involving synthetic, monosubstance pharmaceuticals (WHO, <xref rid="efs2e181112-bib-0024" ref-type="ref">2013</xref>). With a high demand driven by consumer's health concerns, cultural factors, the belief that herbal preparations are natural and thus safe, and since herbal products are often viewed as being balanced and moderate home remedies, thousands of herbal products, including herbal food supplements, are advertised, marketed and distributed via various channels, including pharmacies, natural herbal shops, online retail stores and social media platforms (Raclariu et&#x000a0;al., <xref rid="efs2e181112-bib-0020" ref-type="ref">2018</xref>). Herbal preparations often contain a complex mixture of natural chemicals, the composition of which depends, among others, on plant growth conditions, the part of the plant used for processing and the conditions of processing, i.e. conditions of extraction from the plant. Despite their popularity, the assessment of their safety requires a thorough multidisciplinary scientific investigation and validation of their chemical and biological activities, including potential pharmaceutical, pharmacological and toxicological activities. However, in cases where herbal products are sold as food supplements, surveillance of such herbal products with respect to potential adverse effects (nutrivigilance) remains difficult because these products do not require a medical prescription and are sold as over&#x02010;the&#x02010;counter products. Legislative frameworks that take into account monitoring, consistent documentation and evaluation of adverse effects associated with food supplements are not in place in many EU countries.</p><p>Herbal products&#x02019; regulations vary greatly between countries and continents. In the EU/EEA, herbal products fall into two main categories, depending on their primary intent of use: i) &#x02018;herbal medicines&#x02019; that are regulated under medicinal products&#x02019; legislation and ii) &#x02018;herbal food supplements&#x02019; that are covered by the provisions of food legislation. The European Directive 2002/46/EC defines food supplements as concentrated sources of nutrients or other substances with nutritional or physiological effect whose purpose is to supplement the normal diet. Regarding more specific provisions for nutrients or other substances, the Directive 2002/46/EC so far only regulates which vitamins and minerals may be added to food supplements and which vitamin/mineral substances or compounds may be used. Daily maximum amounts for vitamins and minerals in individual food supplement products have not yet been established at the EU level. With respect to &#x02018;other substances with a nutritional or physiological effect&#x02019;, current specific provisions (with only a few exceptions) are lacking as to which &#x02018;other substances&#x02019; may be used in food supplements or regarding daily maximum amounts for individual substances in food supplement products.</p><p>Though the quality and safety of herbal food supplements need to fulfil the requirements of food legislation, these are, however, considerably less stringent compared to the medicinal products regulations. Thus, unlike drugs, which must be approved by the competent authorities before they can be marketed, food supplement products do not require premarket review or approval within the EU and their safety and conformity with the food law requirements is under the responsibility of manufactures and suppliers.</p><p>
<italic>Annona muricata</italic> L. (Annonacea), known as graviola (Portuguese), guanabana (Spanish), Stachelannone (German) or soursop (English), grows as a tree and is endemic to the warmest areas of the tropics of South and Central America and the Caribbean. In addition, it has been distributed very early to eastern and western Africa, Asia and to south&#x02010;east China (Wahab et&#x000a0;al., <xref rid="efs2e181112-bib-0023" ref-type="ref">2018</xref>). Various preparations from fruits and other plant parts of <italic>A. muricata</italic> are marketed worldwide as over&#x02010;the&#x02010;counter food supplements that are purported to support general health or to treat a wide range of health conditions, particularly cancer and parasitic infections (Badrie and Schauss, <xref rid="efs2e181112-bib-0001" ref-type="ref">2009</xref>; Coria&#x02010;T&#x000e9;llez et&#x000a0;al., <xref rid="efs2e181112-bib-0011" ref-type="ref">2018</xref>). However, open questions remain regarding their safety since Annonaceae have been reported to contain potentially neurotoxic compounds, i.e. acetogenins. <italic>A. muricata</italic> is also listed in the <italic>EFSA Compendium of botanicals reported to contain naturally occurring substances of possible concern for human health when used in food and food supplements</italic> (EFSA, <xref rid="efs2e181112-bib-0013" ref-type="ref">2012</xref>).</p><p>The current risk assessment is intended to evaluate possible health risks associated with the consumption of <italic>A. muricata</italic>&#x02010;based food supplements, based on available published data.</p></sec></sec><sec id="efs2e181112-sec-0005"><label>2</label><title>Description of the work programme</title><p>The hosting Unit in which the work programme was carried out (BfR Unit Nutritional Risks, Allergies and Novel Foods) has long&#x02010;standing experience in risk assessment of food supplements and fortified foods. One of the major areas of its research relates to the risk assessment of &#x02018;other substances&#x02019; with specific nutritional or physiological effects, including the safety assessment of secondary plant ingredients and plant preparations.</p><sec id="efs2e181112-sec-0006"><label>2.1</label><title>Aims</title><p>The aims of the work programme were for the fellow to i) gain experience in performing risk assessment of &#x02018;other substances&#x02019; used in food supplements or fortified foods, with a focus on substances of plant origin (&#x02018;botanicals&#x02019;, i.e. plant preparations and secondary plant compounds); ii) to specifically assess the possible health risks associated with the consumption of <italic>Annona muricata</italic>&#x02010;based food supplements; and iii) to set up further networking and build professional collaboration with the host institution, as well as with other experts in various fields of food risk assessment.</p><p>The activities described below were in line with the aims of the work programme proposed by the BfR.</p></sec><sec id="efs2e181112-sec-0007"><label>2.2</label><title>Activities/methods</title><sec id="efs2e181112-sec-0008"><label>2.2.1</label><title>Preparation of a monograph for the risk assessment of <italic>Annona muricata</italic>
</title><p>Possible health risks associated with the consumption of <italic>A. muricata</italic>&#x02010;containing food supplements were evaluated based on available published data. Risk assessment was performed following the &#x02018;BfR Guidance Document for Health Assessments&#x02019; (BfR, <xref rid="efs2e181112-bib-0003" ref-type="ref">2010</xref>) as well as the EFSA &#x02018;Guidance on Safety assessment of botanicals and botanical preparations intended for use as ingredients in food supplements&#x02019; (EFSA, <xref rid="efs2e181112-bib-0012" ref-type="ref">2009</xref>). A detailed monograph on <italic>A. muricata</italic> was prepared, forming the basis for a publication to be submitted to a peer&#x02010;reviewed scientific journal.</p><p>In the course of the training, the fellow gained experience in i) searches in scientific databases and search strategies to identify relevant scientific publications, ii) systematic data extraction from scientific publications, iii) structuring of scientific data, iv) evaluation of scientific data from individual studies as well as from the overall data situation (i.e. assessment of observed effects, identification of toxicological key parameters, characterisation of dose&#x02013;response relationships), v) methods for derivation of health&#x02010;based guidance values, vi) identification of potentially sensitive groups and groups at risk, vii) structure and content of risk assessment monographs, and viii) scientific writing.</p><p>The corresponding detailed risk assessment report on <italic>A. muricata</italic> is to be submitted for publication in a peer&#x02010;reviewed scientific journal shortly. Therefore, in the context of the present technical report, the workflow, methodology and results of the risk assessment are summarised in brief in the following:</p><p>Scientific databases such as `PubMed/Medline&#x02032;, &#x02018;Scopus&#x02032;, &#x02018;Google Scholar&#x02032; and &#x02018;Web of Science&#x02032; were searched in order to retrieve relevant publications, with the last update being in mid&#x02010;March 2020. Numerous search strategies were used, including different names of the plant species of interest (i.e. &#x02018;<italic>Annona muricata&#x02019;</italic>, &#x02018;soursop&#x02019;, &#x02018;graviola&#x02019;) in connection with terms related to the endpoints of interest, as for instance &#x02018;adverse effects&#x02019;, &#x02018;toxicity&#x02019; or &#x02018;safety&#x02019;. This represented the basis for identifying scientific evidence provided in peer&#x02010;reviewed scientific publications in relation to compounds of potential concern contained in <italic>A. muricata</italic>, alongside with toxicological data and studies reporting adverse health outcomes in humans. Additionally, scientific abstracts, reports as well as pertinent evaluations performed by scientific bodies or national and international authorities dealing with food and drug safety were checked as well. Moreover, the key grey literature was considered, including articles published in non&#x02010;scientific journals, project reports, and other forms of documentation outside of scientific literature.</p><p>Data from the literature studies included in the present risk assessment were retrieved, summarised and arranged, based on the following criteria: 1) chemical composition of constituents of <italic>A. muricata</italic> and of the derived herbal preparations, 2) human studies, 3) acute, subchronic and chronic toxicological animal studies, 4) <italic>in&#x000a0;vitro</italic> studies, and 5) potential pharmakokinetic and pharmacodynamic interaction.</p><p>With respect to constituents of <italic>A. muricata</italic>, about 200 bioactive secondary plant compounds have been isolated and described from <italic>A. muricata</italic>, with the most abundant being annonaceous acetogenins (ACGs), followed by alkaloids, flavonoids and phenols (Leboeuf et&#x000a0;al., <xref rid="efs2e181112-bib-0018" ref-type="ref">2007</xref>; Bonneau et&#x000a0;al., <xref rid="efs2e181112-bib-0004" ref-type="ref">2017</xref>; Coria&#x02010;T&#x000e9;llez et&#x000a0;al., <xref rid="efs2e181112-bib-0011" ref-type="ref">2018</xref>). ACGs have been proposed to have cytotoxic, antitumoral, antimalarian, antiparasitic, antiviral, antimicrobial or immunosuppressant activities, or as pesticidal agents, and some are well known to be potent inhibitors of the mitochondrial complex I (NADH&#x02010;quinone&#x02010;oxidoreductase) in the respiratory chain (Bermejo et&#x000a0;al., <xref rid="efs2e181112-bib-0002" ref-type="ref">2005</xref>; McLaughlin, <xref rid="efs2e181112-bib-0019" ref-type="ref">2008</xref>). Among ACGs, annonacin has been identified as the most abundant in <italic>A. muricata</italic> (Yamada et&#x000a0;al., <xref rid="efs2e181112-bib-0025" ref-type="ref">2014</xref>; Coria&#x02010;T&#x000e9;llez et&#x000a0;al., <xref rid="efs2e181112-bib-0011" ref-type="ref">2018</xref>).</p><p>Several human observational studies were identified (Caparros&#x02010;Lefebvre and Elbaz, <xref rid="efs2e181112-bib-0006" ref-type="ref">1999</xref>; Chaudhuri et&#x000a0;al., <xref rid="efs2e181112-bib-0010" ref-type="ref">2000</xref>; Caparros&#x02010;Lefebvre et&#x000a0;al., <xref rid="efs2e181112-bib-0008" ref-type="ref">2001</xref>; Caparros&#x02010;Lefebvre and Lees, <xref rid="efs2e181112-bib-0007" ref-type="ref">2005</xref>). These studies suggested an association between the long&#x02010;term consumption of fruits and infusions made from other plant parts <italic>of A. muricata</italic> (i.e. leaves) and an increased incidence of movement disorders that resembled Parkinson&#x02032;s disease. In one of these studies. the post&#x02010;mortem neuropathological and biochemical examination of some affected patients showed an accumulation of tau proteins in the midbrain (Caparros&#x02010;Lefebvre et&#x000a0;al., <xref rid="efs2e181112-bib-0008" ref-type="ref">2001</xref>). However, causality in relation to <italic>A. muricata</italic> is difficult to prove and information provided in the observational studies is insufficient in this respect.</p><p>Regarding the use of <italic>A. muricata</italic> in food supplements, scientific information from human intervention studies, which might be used for safety evaluation of <italic>A. muricata,</italic> is currently lacking. This represents a major data gap that impedes risk assessment, especially in the case when long&#x02010;term use of high supplemental <italic>A. muricata</italic> doses is intended. Along these lines, the importance to include a detailed documentation regarding the incidence of adverse effects and measurements of clinical safety parameters in any future intervention studies is underlined.</p><p>Among retrieved animal studies, some &#x02018;classical&#x02019; toxicological <italic>in&#x000a0;vivo</italic> studies showed that the exposure to annonacin (whether in the form of <italic>A. muricata</italic> extracts or as purified phytochemical), induced serious neuropathologies in rodents (Champy et&#x000a0;al., <xref rid="efs2e181112-bib-0009" ref-type="ref">2003</xref>; Lannuzel et&#x000a0;al., <xref rid="efs2e181112-bib-0017" ref-type="ref">2006</xref>; Yamada et&#x000a0;al., <xref rid="efs2e181112-bib-0025" ref-type="ref">2014</xref>). For instance, after i.v. application of annonacin over 28 days to rats, annonacin accumulated in the brain parenchyma, decreased brain ATP levels, induced neuropathological abnormalities in the basal ganglia and loss of nigral and striatal neurons in exposed animals (Champy et&#x000a0;al., <xref rid="efs2e181112-bib-0009" ref-type="ref">2003</xref>). Moreover, following 1&#x02010;year oral exposure to <italic>A. muricata</italic> fruit juice, increased numbers of neurons with phosphorylated tau proteins in several brain regions were observed in wild&#x02010;type and human tau protein transgenic mice (Rottscholl et&#x000a0;al., <xref rid="efs2e181112-bib-0022" ref-type="ref">2016</xref>). No further toxicological long&#x02010;term animal studies with <italic>A. muricata</italic> preparations were identified.</p><p>
<italic>In vitro</italic>, annonacin extracted from the root of <italic>A. muricata</italic> promoted death of dopaminergic neurons in embryonic rat mesencephalic cultured cells and caused tau protein pathology in cultured rat striatal neurons (Lannuzel et&#x000a0;al., <xref rid="efs2e181112-bib-0016" ref-type="ref">2003</xref>, <xref rid="efs2e181112-bib-0017" ref-type="ref">2006</xref>). A high degree of toxicity on Lund human mesencephalic cells was observed after exposure to preparations from marketed dietary supplements containing leaves and stems of <italic>A. muricata</italic> (H&#x000f6;llerhage et&#x000a0;al., <xref rid="efs2e181112-bib-0015" ref-type="ref">2015</xref>).</p><p>Regarding <italic>A. muricata</italic> preparations that might be used in food supplements, the composition of such preparations may differ considerably, depending, among others, on conditions of plant growth, conditions of harvest, part of plant used, method of extraction and further processing of the preparation. Reliable toxicological data, human studies or toxicokinetic <italic>in&#x000a0;vivo</italic> data, however, are currently lacking for specific food supplement products based on <italic>A. muricata</italic> preparations. There is also a lack of reliable <italic>in&#x000a0;vitro</italic> and <italic>in&#x000a0;vivo</italic> studies with respect to potential interactions between <italic>A.&#x000a0;muricata</italic> preparations and conventional drugs.</p><p>In cases where relevant information from safety testing is lacking for certain botanicals and thus the data situation does not provide a sufficient basis for a comprehensive risk assessment, it has been suggested by EFSA to follow a presumption of safety approach. This approach implies that for botanicals traditionally consumed as food, it is assumed that intake, i.e. via supplements or fortified foods, that corresponds to the intake via traditional or normal diet does not pose a risk (EFSA, <xref rid="efs2e181112-bib-0014" ref-type="ref">2014</xref>). However, due to the lack of information on traditional or background exposure to <italic>A. muricata</italic> or constituents thereof via food, the application of the presumption of safety approach for the use of <italic>A.&#x000a0;muricata</italic> and derived preparations, including preparations marketed as herbal food supplements, is currently not feasible.</p><p>In conclusion, risk assessment regarding the consumption of certain <italic>A. muricata&#x02010;</italic>based food supplement products faces a number of challenges, including the lack of standardisation of composition of <italic>A. muricata</italic> preparations used in food supplements and the lack of information from reliable studies with preparations actually used in food supplements.</p></sec><sec id="efs2e181112-sec-0009"><label>2.2.2</label><title>EU&#x02010;FORA Fellowship supporting programme</title><p>During the introductory phase of the fellowship, the fellow obtained general information on risk assessment activities performed within the BfR Department of Food Safety, as well as in the hosting Unit Nutritional Risks, Allergies and Novel Foods. Furthermore, the fellow was supported by appropriate supervision to obtain experience in risk assessment of &#x02018;other substances&#x02019; used in food supplements or fortified foods, with a focus on substances of plant origin (&#x02018;botanicals&#x02019;, i.e. plant preparations and secondary plant compounds) and regular consultations in this regard with the supervisor as well as with other colleagues. At the BfR, the fellow participated in regular short seminars organised by the Department of Food Safety, with presentations on food safety&#x02010;related (<italic>in&#x000a0;vitro</italic> or <italic>in&#x000a0;vivo</italic> experimental) ongoing research activities carried out at different units of the department. During the regular meetings of the host Unit of Nutritional Risks, Allergies and Novel Foods, the fellow presented the EU&#x02010;FORA fellowship programme, as well as the intermediary results of her project on risk assessment of <italic>A.&#x000a0;muricata</italic>. Moreover, the fellow was also given the opportunity to present and discuss the final results of her project within the EU&#x02010;FORA programme at a departmental seminar on 7 July 2020.</p><p>Complementary to the &#x02018;learning by doing&#x02019; placement at the BfR, a 3&#x02010;week general induction training was arranged by EFSA in Parma (Italy) at the start of the Programme (September 2019), as well as other three specific training modules spread over the rest of the 12&#x02010;month period.</p><p>In addition to the scheduled activities regarding the scientific project, the hosting institution, BfR, provided an additional training curriculum, and also enabled the fellow to participate in some other activities that played an important role in developing the general knowledge on risk assessment. For example, the fellow attended the 5th German Pharm&#x02010;Tox Summit 2020 in March 2020 and presented results of her project as a conference poster on that occasion (Raclariu&#x02010;Manolica et&#x000a0;al., <xref rid="efs2e181112-bib-0021" ref-type="ref">2020</xref>). This also provided the opportunity for her to interact with a broad scientific community from academia as well as from regulatory institutions.</p><p>The following Table&#x000a0;1 provides an overview on the supporting activities organised or facilitated for the fellow by the BfR during the EU&#x02010;FORA Fellowship.</p><table-wrap id="efs2e181112-tbl-0001" xml:lang="en" content-type="Table" orientation="portrait" position="float"><label>Table 1</label><caption><p>Supporting activities during the EU&#x02010;FORA Fellowship</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1">Event title</th><th align="left" valign="top" rowspan="1" colspan="1">Date, place</th><th align="left" valign="top" rowspan="1" colspan="1">Note</th></tr></thead><tbody><tr><td align="left" rowspan="2" colspan="1">
<bold>Scientific meetings</bold>
</td><td align="left" rowspan="1" colspan="1">
<p>One Health EJP</p>
<p>Annual Scientific Meeting 2020</p>
</td><td align="left" rowspan="1" colspan="1">27&#x02013;29 May 2020, Online</td><td align="left" rowspan="1" colspan="1">URL: <ext-link ext-link-type="uri" xlink:href="http://www.ohejp2020.com">www.ohejp2020.com</ext-link>
</td></tr><tr><td align="left" rowspan="1" colspan="1">5th German Pharm&#x02010;Tox Summit 2020</td><td align="left" rowspan="1" colspan="1">2&#x02013;5 March 2020, Leipzig University</td><td align="left" rowspan="1" colspan="1">
<p>URL: <ext-link ext-link-type="uri" xlink:href="https://www.gpts-kongress.de/">https://www.gpts-kongress.de/</ext-link>
</p>
<p>Poster presentation: Risk assessment regarding the use of <italic>Annona muricata</italic> in food supplements (Abstract: Raclariu&#x02010;Manolica et&#x000a0;al., <xref rid="efs2e181112-bib-0021" ref-type="ref">2020</xref>)</p>
</td></tr><tr><td align="left" rowspan="7" colspan="1">
<bold>Workshops/Colloquium</bold>
</td><td align="left" rowspan="1" colspan="1">Workshop &#x02018;Risk Assessment and Risk Management of Genetically Modified Organisms (GMO)&#x02019;</td><td align="left" rowspan="1" colspan="1">9 June 2020, BfR, Berlin</td><td align="left" rowspan="1" colspan="1">Tutor: Hermann Broll</td></tr><tr><td align="left" rowspan="1" colspan="1">Workshop &#x02018;Risk Assessment &#x02010; Food contamination by plasticisers&#x02019;</td><td align="left" rowspan="1" colspan="1">5 May 2020, BfR, Berlin</td><td align="left" rowspan="1" colspan="1">Tutors: Dr. Ralph Pirow, Dr. Sebastian Zellmer</td></tr><tr><td align="left" rowspan="1" colspan="1">10th Berlin Workshop on Developmental Toxicology</td><td align="left" rowspan="1" colspan="1">19&#x02013;20 February 2020, BfR, Conference center Berlin Biotechpark</td><td align="left" rowspan="1" colspan="1">URL: <ext-link ext-link-type="uri" xlink:href="https://www.devtox.org/workshops_en.php">https://www.devtox.org/workshops_en.php</ext-link>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Trust &#x02013; how we understand, measure and build it</td><td align="left" rowspan="1" colspan="1">29 January 2020, BfR, Berlin</td><td align="left" rowspan="1" colspan="1">Speaker: Michelle Patel (Food Standards Agency, UK)</td></tr><tr><td align="left" rowspan="1" colspan="1">Creating characters for the BfR as a new line of communication</td><td align="left" rowspan="1" colspan="1">10 January 2020, BfR, Berlin</td><td align="left" rowspan="1" colspan="1">Speaker: Claudio Canales Rios</td></tr><tr><td align="left" rowspan="1" colspan="1">Harmonized exchange of food safety models using web&#x02010;based services from RAKIP and the AGINFRA + project</td><td align="left" rowspan="1" colspan="1">9 December 2019, BfR, Berlin</td><td align="left" rowspan="1" colspan="1">Tutors: Estibaliz Lopez de Abechuco Garrido, Esther Sundermann, Lars Valentin, Miguel de Alba Aparicio, Thomas Sch&#x000fc;ler, Tasja Buschhardt, Matthias Filter</td></tr><tr><td align="left" rowspan="1" colspan="1">Big data and high&#x02010;throughput&#x02010;driven modeling of health effects of environmental agents</td><td align="left" rowspan="1" colspan="1">6 November 2019, BfR, Berlin</td><td align="left" rowspan="1" colspan="1">Speaker: Prof. Roland Grafstr&#x000f6;m, Karolinska Institut, Stockholm, Sweden</td></tr><tr><td align="left" rowspan="2" colspan="1">
<bold>Other activities</bold>
</td><td align="left" rowspan="1" colspan="1">Nanopore Sequencing in Plants: From Greenhouse to Genome</td><td align="left" rowspan="1" colspan="1">18 February 2020, Webinar from Technology Networks</td><td align="left" rowspan="1" colspan="1">Speaker: Maximilian Schmidt</td></tr><tr><td align="left" rowspan="1" colspan="1">An introduction to the BfR library and its services</td><td align="left" rowspan="1" colspan="1">15 November 2019, BfR, Berlin</td><td align="left" rowspan="1" colspan="1">Tutor: Mr. Benedikt Hummel, BfR library</td></tr></tbody></table><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap></sec></sec></sec><sec id="efs2e181112-sec-0010"><label>3</label><title>Conclusions</title><sec id="efs2e181112-sec-0011"><label>3.1</label><title>Conclusions from <italic>A. muricata</italic> risk assessment</title><p>The results of the assessment show that substantial uncertainties exist regarding the safe use of <italic>A.&#x000a0;muricata</italic>&#x02010;based food supplements. The present data provide strong indications of neurotoxic potential of certain <italic>A. muricata</italic> preparations. However, the paucity of adequate studies, particularly related to long&#x02010;term use of <italic>A. muricata</italic> supplements, currently does not allow the establishment of a safe intake level.</p></sec><sec id="efs2e181112-sec-0012"><label>3.2</label><title>Conclusions from the participation in the EU&#x02010;FORA programme</title><p>Participation in the EFSA EU&#x02010;FORA work programme was a valuable opportunity for the fellow to obtain experience in risk assessment of herbal food supplements and other plant preparations. This was also an excellent opportunity for the fellow to consolidate her specialised knowledge and skills in food safety, particularly in herbal food supplements, by working according to European and international guidelines and standards. The general risk assessment methodology applied for this specific project is expected to be further extended and applied by the fellow to other substances with nutritional or physiological effected added to foods and food supplements.</p><p>Moreover, the EU&#x02010;FORA programme provided a great environment to build a strong professional and personal network that will be used for future collaborations.</p></sec></sec><sec id="efs2e181112-sec-0013"><title>Abbreviations</title><p>
<def-list list-type="simple"><def-item><term>ACG</term><def><p>acetogenin</p></def></def-item><def-item><term>BfR</term><def><p>Bundesinstitut f&#x000fc;r Risikobewertung (German Federal Institute for Risk Assessment)</p></def></def-item><def-item><term>EEA</term><def><p>European Economic Area</p></def></def-item><def-item><term>EU&#x02010;FORA</term><def><p>European Union Food Risk Assessment</p></def></def-item><def-item><term>i.v.</term><def><p>intravenous</p></def></def-item><def-item><term>RA</term><def><p>risk assessment</p></def></def-item><def-item><term>WHO</term><def><p>World Health Organization</p></def></def-item></def-list>
</p></sec></body><back><ref-list content-type="cited-references" id="efs2e181112-bibl-0001"><title>References</title><ref id="efs2e181112-bib-0001"><mixed-citation publication-type="book" id="efs2e181112-cit-0001">
<string-name>
<surname>Badrie</surname>
<given-names>N</given-names>
</string-name> and <string-name>
<surname>Schauss</surname>
<given-names>AG</given-names>
</string-name>, <year>2009</year>
<chapter-title>Soursop (Annona muricata L.): composition, nutritional value, medicinal uses, and toxicology</chapter-title> In: <person-group person-group-type="editor"><name name-style="western"><surname>Watson</surname><given-names>RR</given-names></name></person-group> and <person-group person-group-type="editor"><name name-style="western"><surname>Preedy</surname><given-names>VR</given-names></name></person-group> eds, <source xml:lang="en">Bioactive Foods in Promoting Health</source>. <publisher-name>Academic Press</publisher-name>, <publisher-loc>Oxford</publisher-loc> pp. <fpage>621</fpage>&#x02013;<lpage>643</lpage>. ISBN: 978&#x02010;0-12-374628&#x02010;3. <pub-id pub-id-type="doi">10.1016/b978-0-12-374628-3.00039-6</pub-id>
</mixed-citation></ref><ref id="efs2e181112-bib-0002"><mixed-citation publication-type="journal" id="efs2e181112-cit-0002">
<string-name>
<surname>Bermejo</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Figad&#x000e8;re</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Zafra&#x02010;Polo</surname>
<given-names>M&#x02010;C</given-names>
</string-name>, <string-name>
<surname>Barrachina</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Estornell</surname>
<given-names>E</given-names>
</string-name> and <string-name>
<surname>Cortes</surname>
<given-names>D</given-names>
</string-name>, <year>2005</year>
<article-title>Acetogenins from Annonaceae: recent progress in isolation, synthesis and mechanisms of action</article-title>. <source xml:lang="en">Natural Product Reports</source>, <volume>22</volume>, <fpage>269</fpage>&#x02013;<lpage>303</lpage>. <pub-id pub-id-type="doi">10.1039/b500186m</pub-id>
<pub-id pub-id-type="pmid">15806200</pub-id></mixed-citation></ref><ref id="efs2e181112-bib-0003"><mixed-citation publication-type="miscellaneous" id="efs2e181112-cit-0003">
<collab collab-type="authors">BfR</collab>
, German Federal Institute for Risk Assessment, <year>2010</year>
<article-title>Guidance document for health assessments</article-title>. ISBN 3&#x02010;938163&#x02010;72-0.</mixed-citation></ref><ref id="efs2e181112-bib-0004"><mixed-citation publication-type="journal" id="efs2e181112-cit-0004">
<string-name>
<surname>Bonneau</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Baloul</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Bajin Ba Ndob</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Senejoux</surname>
<given-names>F</given-names>
</string-name> and <string-name>
<surname>Champy</surname>
<given-names>P</given-names>
</string-name>, <year>2017</year>
<article-title>The fruit of <italic>Annona squamosa</italic> L. as a source of environmental neurotoxins: from quantification of squamocin to annotation of Annonaceous acetogenins by LC&#x02010;MS/MS analysis</article-title>. <source xml:lang="en">Food Chemistry</source>, <volume>226</volume>, <fpage>32</fpage>&#x02013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodchem.2017.01.042</pub-id>
<pub-id pub-id-type="pmid">28254016</pub-id></mixed-citation></ref><ref id="efs2e181112-bib-0005"><mixed-citation publication-type="journal" id="efs2e181112-cit-0005">
<string-name>
<surname>Bronzwaer</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Gourierec</surname>
<given-names>NL</given-names>
</string-name> and <string-name>
<surname>Koulouris</surname>
<given-names>S</given-names>
</string-name>, <year>2016</year>
<article-title>Editorial: the European Food Risk Assessment Fellowship Programme (EU&#x02010;FORA)</article-title>. <source xml:lang="en">EFSA Journal</source> 2016;<volume>14</volume>(<issue>11</issue>), <fpage>e14111</fpage>
<pub-id pub-id-type="doi">10.2903/j.efsa.2016.e14111</pub-id>
</mixed-citation></ref><ref id="efs2e181112-bib-0006"><mixed-citation publication-type="journal" id="efs2e181112-cit-0006">
<string-name>
<surname>Caparros&#x02010;Lefebvre</surname>
<given-names>D</given-names>
</string-name> and <string-name>
<surname>Elbaz</surname>
<given-names>A</given-names>
</string-name>, <year>1999</year>
<article-title>Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case&#x02010;control study</article-title>. <source xml:lang="en">Caribbean Parkinsonism Study Group. Lancet</source>, <volume>354</volume>, <fpage>281</fpage>&#x02013;<lpage>286</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(98)10166-6</pub-id>
</mixed-citation></ref><ref id="efs2e181112-bib-0007"><mixed-citation publication-type="journal" id="efs2e181112-cit-0007">
<string-name>
<surname>Caparros&#x02010;Lefebvre</surname>
<given-names>D</given-names>
</string-name> and <string-name>
<surname>Lees</surname>
<given-names>AJ</given-names>
</string-name>, <year>2005</year>
<article-title>Atypical unclassifiable parkinsonism on Guadeloupe: an environmental toxic hypothesis</article-title>. <source xml:lang="en">Movement disorders: Official Journal of the Movement Disorder Society</source>, <volume>20</volume>(<issue>S12</issue>), <fpage>S114</fpage>&#x02013;<lpage>S118</lpage>.<pub-id pub-id-type="pmid">16092100</pub-id></mixed-citation></ref><ref id="efs2e181112-bib-0008"><mixed-citation publication-type="journal" id="efs2e181112-cit-0008">
<string-name>
<surname>Caparros&#x02010;Lefebvre</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Sergeant</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Lees</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Camuzat</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Daniel</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Lannuzel</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Brice</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Tolosa</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Delacourte</surname>
<given-names>A</given-names>
</string-name> and <string-name>
<surname>Duyckaerts</surname>
<given-names>C</given-names>
</string-name>, <year>2001</year>
<article-title>Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy&#x02010;like tauopathy</article-title>. <source xml:lang="en">Brain</source>, <volume>125</volume>, <fpage>801</fpage>&#x02013;<lpage>811</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awf086</pub-id>
</mixed-citation></ref><ref id="efs2e181112-bib-0009"><mixed-citation publication-type="journal" id="efs2e181112-cit-0009">
<string-name>
<surname>Champy</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Hoglinger</surname>
<given-names>GU</given-names>
</string-name>, <string-name>
<surname>Feger</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Gleye</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Hocquemiller</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Laurens</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Guerineau</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Laprevote</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Medja</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Lombes</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Michel</surname>
<given-names>PP</given-names>
</string-name>, <string-name>
<surname>Lannuzel</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hirsch</surname>
<given-names>EC</given-names>
</string-name> and <string-name>
<surname>Ruberg</surname>
<given-names>M</given-names>
</string-name>, <year>2003</year>
<article-title>Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats: possible relevance for atypical parkinsonism in Guadeloupe</article-title>. <source xml:lang="en">Journal of Neurochemistry</source>, <volume>88</volume>, <fpage>63</fpage>&#x02013;<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1046/j.1471-4159.2003.02138.x</pub-id>
</mixed-citation></ref><ref id="efs2e181112-bib-0010"><mixed-citation publication-type="journal" id="efs2e181112-cit-0010">
<string-name>
<surname>Chaudhuri</surname>
<given-names>KR</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>MT</given-names>
</string-name> and <string-name>
<surname>Brooks</surname>
<given-names>DJ</given-names>
</string-name>, <year>2000</year>
<article-title>Atypical parkinsonism in Afro&#x02010;Caribbean and Indian origin immigrants to the UK</article-title>. <source xml:lang="en">Move Disorder</source>, <volume>15</volume>, <fpage>18</fpage>&#x02013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1002/1531-8257(200001)15:1&#x0003c;18::aid-mds1005&#x0003e;3.0.co;2-z</pub-id>
</mixed-citation></ref><ref id="efs2e181112-bib-0011"><mixed-citation publication-type="journal" id="efs2e181112-cit-0011">
<string-name>
<surname>Coria&#x02010;T&#x000e9;llez</surname>
<given-names>AV</given-names>
</string-name>, <string-name>
<surname>Montalvo&#x02010;G&#x000f3;nzalez</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Yahia</surname>
<given-names>EM</given-names>
</string-name> and <string-name>
<surname>Obledo&#x02010;V&#x000e1;zquez</surname>
<given-names>EN</given-names>
</string-name>, <year>2018</year>
<article-title>Annona muricata: a comprehensive review on its traditional medicinal uses, phytochemicals, pharmacological activities, mechanisms of action and toxicity</article-title>. <source xml:lang="en">Arabian Journal of Chemistry</source>, <volume>11</volume>, <fpage>662</fpage>&#x02013;<lpage>691</lpage>. <pub-id pub-id-type="doi">10.1016/j.arabjc.2016.01.004</pub-id>
</mixed-citation></ref><ref id="efs2e181112-bib-0012"><mixed-citation publication-type="journal" id="efs2e181112-cit-0012">
<collab collab-type="authors">EFSA</collab>
(European Food Safety Authority), <year>2009</year>
<article-title>Guidance on safety assessment of botanicals and botanical preparations intended for use as ingredients in food supplements</article-title>. <source xml:lang="en">EFSA Journal</source> 2009;<volume>7</volume>(<issue>9</issue>):1249. <ext-link ext-link-type="uri" xlink:href="http://www.efsa.europa.eu/en/efsajournal/pub/1249">http://www.efsa.europa.eu/en/efsajournal/pub/1249</ext-link>
</mixed-citation></ref><ref id="efs2e181112-bib-0013"><mixed-citation publication-type="journal" id="efs2e181112-cit-0013">
<collab collab-type="authors">EFSA</collab>
(European Food Safety Authority), <year>2012</year>
<article-title>Compendium of botanicals reported to contain naturally occurring substances of possible concern for human health when used in food and food supplements</article-title>. <source xml:lang="en">EFSA Journal</source> 2012;<volume>10</volume>(<issue>5</issue>):2663. <pub-id pub-id-type="doi">10.2903/j.efsa.2012.2663</pub-id>
</mixed-citation></ref><ref id="efs2e181112-bib-0014"><mixed-citation publication-type="journal" id="efs2e181112-cit-0014">
<collab collab-type="authors">EFSA</collab>
(European Food Safety Authority), <year>2014</year>
<article-title>Scientific opinion on a qualified presumption of safety (QPS) approach for the safety assessment of botanicals and botanical preparations</article-title>. <source xml:lang="en">EFSA Journal</source> 2014;<volume>12</volume>(<issue>3</issue>):3593. <pub-id pub-id-type="doi">10.2903/j.efsa.2014.3593</pub-id>
</mixed-citation></ref><ref id="efs2e181112-bib-0015"><mixed-citation publication-type="journal" id="efs2e181112-cit-0015">
<string-name>
<surname>H&#x000f6;llerhage</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>R&#x000f6;sler</surname>
<given-names>TW</given-names>
</string-name>, <string-name>
<surname>Berjas</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Luo</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Tran</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Richards</surname>
<given-names>KM</given-names>
</string-name>, <string-name>
<surname>Sabaa&#x02010;Srur</surname>
<given-names>AU</given-names>
</string-name>, <string-name>
<surname>Maia</surname>
<given-names>JGS</given-names>
</string-name>, <string-name>
<surname>de Moraes</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Godoy</surname>
<given-names>HT</given-names>
</string-name>, <string-name>
<surname>H&#x000f6;glinger</surname>
<given-names>GU</given-names>
</string-name> and <string-name>
<surname>Smith</surname>
<given-names>RE</given-names>
</string-name>, <year>2015</year>
<article-title>Neurotoxicity of dietary supplements from Annonaceae species</article-title>. <source xml:lang="en">International Journal of Toxicology</source>, <volume>34</volume>, <fpage>543</fpage>&#x02013;<lpage>550</lpage>. <pub-id pub-id-type="doi">10.1177/1091581815602252</pub-id>
<pub-id pub-id-type="pmid">26405269</pub-id></mixed-citation></ref><ref id="efs2e181112-bib-0016"><mixed-citation publication-type="journal" id="efs2e181112-cit-0016">
<string-name>
<surname>Lannuzel</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Michel</surname>
<given-names>PP</given-names>
</string-name>, <string-name>
<surname>Hoglinger</surname>
<given-names>GU</given-names>
</string-name>, <string-name>
<surname>Champy</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Jousset</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Medja</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Lombes</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Darios</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Gleye</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Laurens</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hocquemiller</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Hirsch</surname>
<given-names>EC</given-names>
</string-name> and <string-name>
<surname>Ruberg</surname>
<given-names>M</given-names>
</string-name>, <year>2003</year>
<article-title>The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism</article-title>. <source xml:lang="en">Neuroscience</source>, <volume>121</volume>, <fpage>287</fpage>&#x02013;<lpage>296</lpage>. <pub-id pub-id-type="doi">10.1016/s0306-4522(03)00441-x</pub-id>
<pub-id pub-id-type="pmid">14521988</pub-id></mixed-citation></ref><ref id="efs2e181112-bib-0017"><mixed-citation publication-type="journal" id="efs2e181112-cit-0017">
<string-name>
<surname>Lannuzel</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hoglinger</surname>
<given-names>GU</given-names>
</string-name>, <string-name>
<surname>Champy</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Michel</surname>
<given-names>PP</given-names>
</string-name>, <string-name>
<surname>Hirsch</surname>
<given-names>EC</given-names>
</string-name> and <string-name>
<surname>Ruberg</surname>
<given-names>M</given-names>
</string-name>, <year>2006</year>
<article-title>Is atypical parkinsonism in the Caribbean caused by the consumption of Annonacae?</article-title>
<source xml:lang="en">Journal of Neural Transmission. Supplementum</source>, <volume>70</volume>, <fpage>153</fpage>&#x02013;<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-211-45295-0_24</pub-id>
</mixed-citation></ref><ref id="efs2e181112-bib-0018"><mixed-citation publication-type="journal" id="efs2e181112-cit-0018">
<string-name>
<surname>Leboeuf</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Legueut</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Cav&#x000e9;</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Desconclois</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Forgacs</surname>
<given-names>P</given-names>
</string-name> and <string-name>
<surname>Jacquemin</surname>
<given-names>H</given-names>
</string-name>, <year>2007</year>
<article-title>Alcalo&#x000ef;des des Annonac&#x000e9;es XXIX: Alcalo&#x000ef;des de l'Annona muricata L</article-title>. <source xml:lang="en">Planta Medica</source>, <volume>42</volume>, <fpage>37</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1055/s-2007-971543</pub-id>
</mixed-citation></ref><ref id="efs2e181112-bib-0019"><mixed-citation publication-type="journal" id="efs2e181112-cit-0019">
<string-name>
<surname>McLaughlin</surname>
<given-names>JL</given-names>
</string-name>, <year>2008</year>
<article-title>Paw paw and cancer: annonaceous acetogenins from discovery to commercial products</article-title>. <source xml:lang="en">Journal of Natural Products</source>, <volume>71</volume>, <fpage>1311</fpage>&#x02013;<lpage>1321</lpage>. <pub-id pub-id-type="doi">10.1021/np800191t</pub-id>
<pub-id pub-id-type="pmid">18598079</pub-id></mixed-citation></ref><ref id="efs2e181112-bib-0020"><mixed-citation publication-type="journal" id="efs2e181112-cit-0020">
<string-name>
<surname>Raclariu</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Heinrich</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ichim</surname>
<given-names>MC</given-names>
</string-name> and <string-name>
<surname>de Boer</surname>
<given-names>H</given-names>
</string-name>, <year>2018</year>
<article-title>Benefits and limitations of DNA barcoding and metabarcoding in herbal product authentication</article-title>. <source xml:lang="en">Phytochemical Analysis</source>, <volume>29</volume>, <fpage>123</fpage>&#x02013;<lpage>128</lpage>. <pub-id pub-id-type="doi">10.1002/pca.2732</pub-id>
<pub-id pub-id-type="pmid">28906059</pub-id></mixed-citation></ref><ref id="efs2e181112-bib-0021"><mixed-citation publication-type="journal" id="efs2e181112-cit-0021">
<string-name>
<surname>Raclariu&#x02010;Manolica</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Bakhiya</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Lampen</surname>
<given-names>A</given-names>
</string-name> and <string-name>
<surname>Hirsch&#x02010;Ernst</surname>
<given-names>K</given-names>
</string-name>, <year>2020</year>
<article-title>Risk assessment of the use of <italic>Annona muricata</italic> in food supplements</article-title>. <source xml:lang="en">Naunyn&#x02010;Schmiedeberg&#x02032;s Arch Pharmacol</source>, <volume>393</volume>(<issue>Suppl 1</issue>), <fpage>Poster 82</fpage>.</mixed-citation></ref><ref id="efs2e181112-bib-0022"><mixed-citation publication-type="journal" id="efs2e181112-cit-0022">
<string-name>
<surname>Rottscholl</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Haegele</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Jainsch</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Respondek</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Hollerhage</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Rosler</surname>
<given-names>TW</given-names>
</string-name>, <string-name>
<surname>Bony</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Le Ven</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Guerineau</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Schmitz&#x02010;Afonso</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Champy</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Oertel</surname>
<given-names>WH</given-names>
</string-name>, <string-name>
<surname>Yamada</surname>
<given-names>ES</given-names>
</string-name> and <string-name>
<surname>Hoglinger</surname>
<given-names>GU</given-names>
</string-name>, <year>2016</year>
<article-title>Chronic consumption of <italic>Annona muricata</italic> juice triggers and aggravates cerebral tau phosphorylation in wild&#x02010;type and MAPT transgenic mice</article-title>. <source xml:lang="en">Journal of Neurochemistry</source>, <volume>139</volume>, <fpage>624</fpage>&#x02013;<lpage>639</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.13835</pub-id>
<pub-id pub-id-type="pmid">27569447</pub-id></mixed-citation></ref><ref id="efs2e181112-bib-0023"><mixed-citation publication-type="journal" id="efs2e181112-cit-0023">
<string-name>
<surname>Wahab</surname>
<given-names>ASM</given-names>
</string-name>, <string-name>
<surname>Jantan</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Haque</surname>
<given-names>MA</given-names>
</string-name> and <string-name>
<surname>Arshad</surname>
<given-names>L</given-names>
</string-name>, <year>2018</year>
<article-title>Exploring the Leaves of <italic>Annona muricata</italic> L. as a source of potential anti&#x02010;inflammatory and anticancer agents</article-title>. <source xml:lang="en">Frontiers in Pharmacology</source>, <volume>9</volume>, <fpage>661</fpage>
<pub-id pub-id-type="doi">10.3389/fphar.2018.00661</pub-id>
<pub-id pub-id-type="pmid">29973884</pub-id></mixed-citation></ref><ref id="efs2e181112-bib-0024"><mixed-citation publication-type="miscellaneous" id="efs2e181112-cit-0024">
<collab collab-type="authors">WHO</collab>
(World Health Organization), <year>2013</year>
<article-title>WHO traditional medicine strategy: 2014&#x02010;2023</article-title>. Available online: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/medicines/publications/traditional/trm_strategy14_23/en/">http://www.who.int/medicines/publications/traditional/trm_strategy14_23/en/</ext-link>
</mixed-citation></ref><ref id="efs2e181112-bib-0025"><mixed-citation publication-type="journal" id="efs2e181112-cit-0025">
<string-name>
<surname>Yamada</surname>
<given-names>ES</given-names>
</string-name>, <string-name>
<surname>Respondek</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Mussner</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>de Andrade</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hollerhage</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Depienne</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Rastetter</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Tarze</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Friguet</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Salama</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Champy</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Oertel</surname>
<given-names>WH</given-names>
</string-name> and <string-name>
<surname>Hoglinger</surname>
<given-names>GU</given-names>
</string-name>, <year>2014</year>
<article-title>Annonacin, a natural lipophilic mitochondrial complex I inhibitor, increases phosphorylation of tau in the brain of FTDP&#x02010;17 transgenic mice</article-title>. <source xml:lang="en">Experimental Neurology</source>, <volume>253</volume>, <fpage>113</fpage>&#x02013;<lpage>125</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2013.12.017</pub-id>
<pub-id pub-id-type="pmid">24389273</pub-id></mixed-citation></ref></ref-list></back></article>